|
.
Agenda
Day 2- November 9, 2005
8:00 am
Registration & Continental Breakfast
8:20 am
Welcome and Opening Remarks
Speaker: David Wanetick, Managing Director,
Gateway Research
8:30 am
Panel Discussion: Funding Wireless Plays
A discussion of where the capital is heading:
RFID, WiMax, WiFi, WLANs, 4G, and mobile gaming.
Panelists:
Brian Rich, Catalyst Investors
Mark Ein, VentureHouse Group
Chris Sugden, Edison Venture Fund
Robert Brill - Newlight Associates
9:15
am
SensorLogic
A comprehensive solution that uses wired and wireless communication networks to connect, automate, optimize, and proactively control remote assets and equipment.
Speaker: Ray Hood, President & CEO
9:45 am
Company Presentation
10:15 am
Networking Break
10:45 am
Concuity
Concuity offers leading-edge technology and service
solutions to optimize contract profitability and
improve operational efficiencies across the entire
healthcare enterprise.
Speaker: Robert E. Watson, President & CEO
11:15 am
Panel Discussion: Funding Software Companies
A discussion of open-source software, enterprise
software, supply chain management, CRM and data capture plays.
Moderator: Sammy Desai, Needham & Co.
Panelists: Greg Frank, Ovation Capital
Chip Hazard, IDG Ventures
Peter Roberts, Longworth Venture Partners
Bobby Goswami, ABS Capital
12:00 pm
Luncheon
1:15 pm
Intellectual Property
Learn how entrepreneurs and venture capitalists
should work together to maximize the value of their
resident intellectual property. Listen to insights regarding the ownership, infringement, valuation,
commercialization potential and defensibility of intellectual property. Learn how the Patent Reform Act
may impact the methods for granting patents, granting of injunctions, and the length of patent review.
Speaker: David Leit, Counsel, Lowenstein Sandler PC
2:00 pm
Company Presentation
2:30 pm
Durect Corporation
Pioneering the development in commercialization of pharmaceutical systems for the treatment of chronic debilitating diseases.
Speaker: Schond L. Greenway, Executive Director
3:00 pm
Panel Discussion: Funding Health Technology Companies
With uncertainty about federal regulation, including
price controls, FDA safety concerns, and the massive Medicare drug
plan, early stage health care investors are finding that it’s a long way to the
top. This session will assess the most promising investment opportunities among ophthalmology,
aesthetics, diabetes, drug devices and women’s health issues.
Panelists: Daniel Lubin, Radius Ventures
Michael D. Kaswan, KBL Healthcare Ventures
Lee R. Wrubel, MD, Foundation Medical Partners
3:45
pm
Panel Discussion: Investment Bankers’ Perspectives on Positioning for the Exit
A discussion of how venture-backed companies
can best position themselves for IPOs, buyouts or
sustainable growth.
Panelists: James Rowan, Legg Mason
Kee Colen, Oppenheimer
5:00 pm
Cocktail Reception & Adjournment
*agenda
subject to change
|
